Evidence map›Paper›PMID 35987973›Full record

ArticleActa neurologica Belgica2023

Investigation of non-motor symptoms in patients with amyotrophic lateral sclerosis.

Takehisa Hirayama, Mari Shibukawa, Masaru Yanagihashi, Hitoshi Warita, Naoki Atsuta, Koji Yamanaka, Osamu Kano

Open access · hybridAbstract read
In one paragraph

Article in Acta neurologica Belgica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Prevalence and correlates of fatigue in amyotrophic lateral sclerosis: A systematic review and meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Pooled it
  2. Trial
  3. Observational
  4. Article
  5. Interplay between B vitamins, fiber, andFrontiers in microbiology · 2026
    Article
  6. Observational
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Takehisa HirayamaDepartment of Neurology, Faculty of Medicine, Toho University, Tokyo, Japan.ORCID http://orcid.org/0000-0002-3056-3176
Mari ShibukawaDepartment of Neurology, Faculty of Medicine, Toho University, Tokyo, Japan.
Masaru YanagihashiDepartment of Neurology, Faculty of Medicine, Toho University, Tokyo, Japan.
Hitoshi WaritaDepartment of Neurology, Tohoku University Hospital, Sendai, Japan.
Naoki AtsutaDepartment of Neurology, Aichi Medical University School of Medicine, Nagakute, Japan.
Koji YamanakaDepartment of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan.
Osamu KanoDepartment of Neurology, Faculty of Medicine, Toho University, Tokyo, Japan. osamu.kano@med.toho-u.ac.jp.
Toho University · JPAichi Medical University · JPNagoya University · JPTohoku University Hospital · JP

Funding

Japan Agency for Medical Research and Development 22wm0425014h0001
6 · The paper itself

Abstract

[Objective] Few studies have comprehensively investigated the non-motor symptoms of amyotrophic lateral sclerosis (ALS). We aimed to investigate this aspect of ALS. [Methods] We held a nationwide webinar, titled "ALS Café," and distributed self-report questionnaires to ALS patients. In addition to the frequency of non-motor symptoms such as fatigue, pain, sleep disorders, defecation disorders, sialorrhea, and sexual problems, we evaluated the quality of life (QoL), ALS Functional Rating Scale-Revised (ALSFRS-R), and Patient Health Questionnaire-9 (PHQ-9). [Results] The average age of the 33 respondents (19 male, 14 female) was 60.8 ± 11.2; 96.7% of respondents had some non-motor symptoms. The median ALSFRS-R was 32.0, and seven (21.2%) of the respondents had a PHQ-9 score of 10 or higher. Fatigue was the most common non-motor symptom (81.8%), followed by pain (60.6%), defecation disorders (57.6%), sleep disorders (48.5%), sialorrhea (48.5%), and sexual problems (24.2%). Fatigue was more frequent in females (P = 0.03). Among the non-motor symptoms, pain was the most common factor affecting QoL, followed by fatigue. More than 90% of ALS patients answered that they had never consulted a physician/counselor about sexual problems. Patients with pain had higher PHQ-9 scores than those without (P = 0.01). There was no correlation between the ALSFRS-R score and QoL and PHQ-9. [Conclusions] Most patients with amyotrophic lateral sclerosis had non-motor symptoms, and fatigue and pain were the most common. We showed that many non-motor symptoms affected QoL without correlating with ALSFRS-R score. Attention should be paid to those even if the motor symptoms of ALS are mild.

Indexed as

Amyotrophic Lateral SclerosisSialorrheaSleep Wake DisordersFatigueFemaleHumansMalePainQuality of LifeAmyotrophic lateral sclerosisFatigueNon-motor symptomsPainQuality of life

Identifiers

PMID35987973
PMCPMC10505101
OpenAlexW4292466982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.